Mobia Medical, Inc.
Research Mobia Medical, Inc. (MOBI) on Bullrun: market cap USD 351.70M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMOBI
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 351.70M
- Financial periodQ1 2026
- RevenueUSD 12.07M
- Net income-USD 17.74M
- Free cash flow-USD 17.77M
- Gross margin82.3%
Valuation Snapshot
latest market cap is USD 351.70M.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 351.70M | n/a | n/a | n/a |
About Mobia Medical, Inc.
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Mobia Medical, Inc.'s market cap?
Mobia Medical, Inc.'s market capitalization is USD 351.70M.
What does Mobia Medical, Inc. do?
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients.